Direct protein transfer to terminally differentiated muscle cells

[1]  G. Pari,et al.  Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. , 1999, Human gene therapy.

[2]  G. Elliott,et al.  Herpes Simplex Virus Type 1 Tegument Protein VP22 Induces the Stabilization and Hyperacetylation of Microtubules , 1998, Journal of Virology.

[3]  A. Phelan,et al.  Intercellular delivery of functional p53 by the herpesvirus protein VP22 , 1998, Nature Biotechnology.

[4]  H. Leonhardt,et al.  Mapping and Use of a Sequence that Targets DNA Ligase I to Sites of DNA Replication In Vivo , 1997, The Journal of cell biology.

[5]  I. Verma,et al.  Gene therapy - promises, problems and prospects , 1997, Nature.

[6]  G. Elliott,et al.  Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein , 1997, Cell.

[7]  H. Leonhardt,et al.  A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei , 1992, Cell.

[8]  G. Elliott,et al.  The herpes simplex virus type 1 tegument protein VP22 is encoded by gene UL49. , 1992, The Journal of general virology.

[9]  Y. Gluzman.  SV40-transformed simian cells support the replication of early SV40 mutants , 1981, Cell.

[10]  H. Kaerner,et al.  Virus-specific basic phosphoproteins associated with herpes simplex virus type a (HSV-1) particles and the chromatin of HSV-1-infected cells. , 1980, The Journal of general virology.

[11]  G. Elliott,et al.  Intercellular trafficking of VP22-GFP fusion proteins , 1999, Gene Therapy.

[12]  A. Phelan,et al.  Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22 , 1999, Gene Therapy.

[13]  P. Koch,et al.  Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells , 1998, Gene Therapy.